We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Olfactory Receptors May Be Metalloproteins

By Biotechdaily staff writers
Posted on 12 Mar 2003
Based on new findings, researchers hypothesize that metalloproteins, proteins capable of binding metal ions, play a major role as olfactory receptors. More...
The findings appeared February 27, 2003, in the online edition of the Proceedings of the National Academy of Sciences.

The average human nose can detect nearly 10,000 distinct scents, which requires about 1,000 olfactory genes, or roughly 3 % of the human genome. About 75% of the proteins coded by the olfactory genes have structures that suggest they could strongly bind metal ions. Investigators from the University of Illinois (Urbana-Champaign, USA) made synthetic peptide analogs of the potential binding site in the olfactory receptor proteins. Metal ions, particularly zinc and copper, bound very strongly to the peptides.

The researchers then used computer models to develop a theory to explain the relationship between the binding of metal ions to olfactory receptors and the sense of smell. When a long peptide loop containing the metal ion slides into the cell membrane, a portion of the receptor protein's fourth helix is pushed outside the membrane. When an odorant binds to the metal ion, the loop is ejected from the membrane, and the fourth helix is dragged back in, triggering a sequence of events leading to nerve cell activity. Then, when the odorant leaves the metal ion, the process can repeat.

"Computer simulations initially put this big loop outside the cell membrane because the loop is negatively charged,” explained senior author Dr. Kenneth Suslick, professor of chemistry at the University of Illinois. "When a positively charged metal ion binds to the site, however, the loop's charge is neutralized, so the computer places the loop in the membrane.”

"Another piece to this puzzle is that one of the first symptoms of dietary zinc deficiency is loss of the sense of smell,” Dr. Suslick said. "That, too, is keeping with this idea that the olfactory receptors are metalloproteins.”



Related Links:
University of Illinois

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.